AI Model Creates Proteins for Gene Therapy Delivery

University of Toronto uses ProteinVAE AI to enhance gene therapy by redesigning hexons and reducing immune responses

[{"selector":"#anim-03fa0ec5-dab2-48e8-a146-85bf8a6c7931","keyframes":{"transform":["translate3d(-128.5%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a676c258-166a-477e-baba-c641433c1530","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e48722d1-7b26-4d24-b578-a52a7be71137","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}]

Immune responses limit the potential of hexons in gene therapy, leading to decreased efficacy and adverse effects.

[{"selector":"#anim-7bb79ae8-7c8e-4a4e-a5be-25703ea4e3cf","keyframes":{"transform":["translate3d(-130.00001%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9968cdfd-2fb3-4a9d-8cf4-f2dc68dca976","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-91d75784-4483-4ab5-b0f5-f29ec4ae24e4","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}]

Hexon variants, crafted by AI, aim to be unrecognizable by the immune system, addressing immune response challenges in gene therapy.

[{"selector":"#anim-03396951-585a-45f8-85a8-6a2c3dcdcd30","keyframes":{"transform":["translate3d(-130.00001%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c3b284c9-67dd-43c7-9f3b-f8dfa2960425","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b4545f69-9c16-4775-834c-43b00e155f5e","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}]

ProteinVAE, a lightweight AI framework, offers a cost-effective and rapid solution for protein design compared to traditional methods.

[{"selector":"#anim-7bea0bde-2062-4f99-9a03-754155d201ea","keyframes":{"transform":["translate3d(-140.00001%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ea146f4f-726d-4eea-af64-842543c1bef4","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a86dadc4-631a-4928-93bf-715bdcaaf0b7","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}]

ProteinVAE's potential extends beyond gene therapy, suggesting a broader application in designing therapeutic entities for various medical treatments using generative AI.

[{"selector":"#anim-166ccdd7-ebe7-439a-b5da-b6002928e058","keyframes":{"transform":["translate3d(-117.45455%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-eef3893c-e991-4944-9c27-e3a1e98a8b2e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ad161850-8745-43a9-970b-94b1d9ca7636","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}]

AI Model Creates Proteins for Gene Therapy Delivery

University of Toronto uses ProteinVAE AI to enhance gene therapy by redesigning hexons and reducing immune responses

Immune responses limit the potential of hexons in gene therapy, leading to decreased efficacy and adverse effects.

Hexon variants, crafted by AI, aim to be unrecognizable by the immune system, addressing immune response challenges in gene therapy.

ProteinVAE, a lightweight AI framework, offers a cost-effective and rapid solution for protein design compared to traditional methods.

ProteinVAE's potential extends beyond gene therapy, suggesting a broader application in designing therapeutic entities for various medical treatments using generative AI.

Read more stories